Leonard Schleifer
Net worth: 1 484 M $ as of 31/05/2026
Net worth: 1 484 M $ as of 31/05/2026
Founder of Regeneron Pharmaceuticals, Inc., Leonard S. Schleifer is Co-President, Chief Executive Officer & Director at this company. He previously was Assistant Professor at Weill Cornell Medical College. Dr. Schleifer received a doctorate from the University of Virginia.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 14/04/2026 | 1,725,565 ( 82.56% ) | 1 061 M $ | 31/05/2026 | |
| 14/04/2026 | 688,088 ( 0.67% ) | 423 M $ | 31/05/2026 |
| Companies | Position | Start |
|---|---|---|
| REGENERON PHARMACEUTICALS, INC. | Chief Executive Officer | 08/01/1988 |
Regeneron Ireland DAC
Regeneron Ireland DAC BiotechnologyHealth Technology Operates as a biotechnology company which develops medicines for serious diseases | Chief Executive Officer | 01/01/2013 |
| Companies | Position | End |
|---|---|---|
Weill Cornell Medical College
Weill Cornell Medical College Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 5 |
|---|---|
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops, manufactures and commercializes medicines for diseases | Health Technology |
University of Virginia
University of Virginia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cornell University
Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Weill Cornell Medical College
Weill Cornell Medical College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Regeneron Ireland DAC
Regeneron Ireland DAC BiotechnologyHealth Technology Operates as a biotechnology company which develops medicines for serious diseases | Health Technology |
Select your edition
All financial news and data tailored to specific country editions